Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND BUB1B, BUBR1, 701, ENSG00000156970, SSK1, BUB1beta, MAD3L, hBUBR1, Bub1A, O60566 AND Treatment
73 results:

  • 1. Using tumor habitat-derived radiomic analysis during pretreatment
    Zhao H; Su Y; Wang Y; Lyu Z; Xu P; Gu W; Tian L; Fu P
    Cancer Imaging; 2024 Feb; 24(1):26. PubMed ID: 38342905
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Low Anterior Resection Syndrome in Total Mesorectal Excision: Risk Factors and Its Relationship with Quality of Life.
    Zhu Y; Ding X; Xiong W; Yang G; Si M; Yan H
    J Laparoendosc Adv Surg Tech A; 2024 Mar; 34(3):199-206. PubMed ID: 38010240
    [No Abstract]    [Full Text] [Related]  

  • 3. Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With RAS Wild-type, Left-Sided Metastatic colorectal cancer: A Randomized Clinical Trial.
    Watanabe J; Muro K; Shitara K; Yamazaki K; Shiozawa M; Ohori H; Takashima A; Yokota M; Makiyama A; Akazawa N; Ojima H; Yuasa Y; Miwa K; Yasui H; Oki E; Sato T; Naitoh T; Komatsu Y; Kato T; Hihara M; Soeda J; Misumi T; Yamamoto K; Akagi K; Ochiai A; Uetake H; Tsuchihara K; Yoshino T
    JAMA; 2023 Apr; 329(15):1271-1282. PubMed ID: 37071094
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Delaying surgery for optimization after colonic stent bridging is safe for left-sided malignant large bowel obstruction: Result from 10-year experience and risks factor analysis.
    Ho MF; Futaba K; Chu S; Hon SS; Ng SS
    Surg Oncol; 2023 Apr; 47():101918. PubMed ID: 36841088
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Association between adjuvant therapy and survival in colorectal cancer patients according to metabolic Warburg-subtypes.
    Offermans K; Jenniskens JCA; Simons CCJM; Samarska I; Fazzi GE; Smits KM; Schouten LJ; Weijenberg MP; Grabsch HI; van den Brandt PA
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6271-6282. PubMed ID: 36723668
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Identification of microsatellite instability and immune-related prognostic biomarkers in colon adenocarcinoma.
    Sun Z; Li G; Shang D; Zhang J; Ai L; Liu M
    Front Immunol; 2022; 13():988303. PubMed ID: 36275690
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic colorectal cancer (VITALITY Study).
    Wang F; He MM; Xiao J; Zhang YQ; Yuan XL; Fang WJ; Zhang Y; Wang W; Hu XH; Ma ZG; Yao YC; Zhuang ZX; Zhou FX; Ying JE; Yuan Y; Zou QF; Guo ZQ; Wu XY; Jin Y; Mai ZJ; Wang ZQ; Qiu H; Guo Y; Shi SM; Chen SZ; Luo HY; Zhang DS; Wang FH; Li YH; Xu RH
    Clin Cancer Res; 2022 Oct; 28(19):4232-4239. PubMed ID: 35929990
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The Persistence of Poverty and its Impact on cancer Diagnosis, treatment and Survival.
    Papageorge MV; Woods AP; de Geus SWL; Ng SC; McAneny D; Tseng JF; Kenzik KM; Sachs TE
    Ann Surg; 2023 Jun; 277(6):995-1001. PubMed ID: 35796386
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prognostic Role of Low-Skeletal Muscle Mass on Staging Computed Tomography in Metastasized colorectal cancer: A Systematic Review and Meta-Analysis.
    Meyer HJ; Strobel A; Wienke A; Surov A
    Clin Colorectal Cancer; 2022 Sep; 21(3):e213-e225. PubMed ID: 35792019
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Efficacy and safety of total neoadjuvant therapy versus neoadjuvant chemoradiotherapy in the treatment of locally advanced rectal cancer: a meta-analysis].
    Zhang YQ; Sun KG; Lu JY; Ma J; Yao N; Qin ZH; Yao YH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jun; 25(6):531-538. PubMed ID: 35754218
    [No Abstract]    [Full Text] [Related]  

  • 11. Effect of KRAS codon 12 or 13 mutations on survival with trifluridine/tipiracil in pretreated metastatic colorectal cancer: a meta-analysis.
    Yoshino T; Van Cutsem E; Li J; Shen L; Kim TW; Sriuranpong V; Xuereb L; Aubel P; Fougeray R; Cattan V; Amellal N; Ohtsu A; Mayer RJ
    ESMO Open; 2022 Jun; 7(3):100511. PubMed ID: 35688062
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Temporary vs. permanent stoma: factors associated with the development of complications and costs for rectal cancer patients.
    Jabbal IS; Spaulding AC; Lemini R; Borkar SR; Stanek K; Colibaseanu DT
    Int J Colorectal Dis; 2022 Apr; 37(4):823-833. PubMed ID: 35201413
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Analysis of related factors of prognosis after surgical treatment of patients with non-metastatic colorectal cancer and construction of a normagram prediction model].
    Liu SX; Zhang L; Shi YK; Han XH
    Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):167-172. PubMed ID: 35184461
    [No Abstract]    [Full Text] [Related]  

  • 14. Late-Stage Diagnosis and Cost of colorectal cancer treatment in Two State Medicaid Programs.
    Hoover S; Subramanian S; Sabatino SA; Khushalani JS; Tangka FKL
    J Registry Manag; 2021; 48(1):20-27. PubMed ID: 34170892
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A systematic review and meta-analysis comparing surgical and oncological outcomes of upper rectal, rectosigmoid and sigmoid tumours.
    Morarasu S; O'Brien L; Clancy C; Dietrich D; Maurer CA; Frasson M; Garcia-Granero E; Martin ST
    Eur J Surg Oncol; 2021 Sep; 47(9):2421-2428. PubMed ID: 34016500
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Prognosis Comparisons of Laparoscopy versus Open Surgery for Rectal cancer Patients after Preoperative Chemoradiotherapy: A Meta-Analysis.
    Niu JW; Ning W; Liu ZZ; Pei DP; Meng FQ; Zhou L
    Oncol Res Treat; 2021; 44(5):261-268. PubMed ID: 33910201
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Incidence Rates, treatment, and Survival of Rectal cancer Among Young Patients: A Nationwide Cohort Study.
    Ramai D; Ofosu A; Solanki V; Lai JK; Barakat M; Dhaliwal A; Aamar A; Aloreidi K; Mohan BP; Reddy M; Adler DG
    J Clin Gastroenterol; 2021 Jul; 55(6):534-541. PubMed ID: 33464029
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Intratumoural immune signature to identify patients with primary colorectal cancer who do not require follow-up after resection: an observational study.
    Primrose JN; Pugh SA; Thomas G; Ellis M; Moutasim K; Mant D
    Health Technol Assess; 2021 Jan; 25(2):1-32. PubMed ID: 33416473
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Clinical Implications of cancer Stem Cell Markers and ABC Transporters as a Predictor of Prognosis in colorectal cancer Patients.
    Kim BH; Oh HK; Kim DW; Kang SB; Choi Y; Shin E
    Anticancer Res; 2020 Aug; 40(8):4481-4489. PubMed ID: 32727778
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Identification of Four Pathological Stage-Relevant Genes in Association with Progression and Prognosis in Clear Cell Renal Cell Carcinoma by Integrated Bioinformatics Analysis.
    Xu D; Xu Y; Lv Y; Wu F; Liu Y; Zhu M; Chen D; Bai B
    Biomed Res Int; 2020; 2020():2137319. PubMed ID: 32309427
    [TBL] [Abstract] [Full Text] [Related]  


    of 4.